News

April 21, 2020

Apr 20, 2020 | Julia Karow NEW YORK – Two months into the COVID-19 pandemic, the number of SARS-CoV-2 molecular diagnostic tests across the US remains woefully inadequate. According to the COVID Tracking Project, a volunteer effort to track testing across the country headed by The Atlantic, more than...

April 14, 2020

Tuesday, April 14, 2020 | Mike May Delving into a single cell’s DNA reveals a reductionist’s dream. By unraveling the identity and order of nucleic acids in just one cell, scientists can explore some of the most basic biology, and clinicians can better understand and treat more diseases. With...

February 24, 2020

DURHAM, February 24, 2020 — BioSkryb, Inc., a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, today announced that it is partnering with Argonaut Manufacturing Services, a contract manufacturing organization (CMO) serving the life science and molecular diagnostics markets, to scale production of...

January 23, 2020

Jan 23, 2020 | Andrew P. Han NEW YORK – A North Carolina startup is hoping to take genomic research to the single-cell level, with a new whole-genome amplification technology. “I haven’t done bulk RNA sequencing in probably five years,” said Charles Gawad, cofounder of Durham, North Carolina-based BioSkryb...

January 9, 2020

DURHAM – BioSkryb, a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, today announced it raised $11.5 million in new funding. This Seed round was led by venture capital firm Anzu Partners and included the law firm Wilson Sonsini Goodrich & Rosati. The...